Biosimilars, Magazine and Packaging

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

JUNE 23, 2025

Alvotech has moved one step closer to entering the Eylea (aflibercept 2 mg) biosimilar market, after a European Medicines Agency (EMA) panel recommended approval of its copycat biologic. Go deeper with GlobalData Reports LOA and PTSR Model - Aflibercept Biosimilar in Age Related Macular. CucuMberStudio via Shutterstock.

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Reports Prescriber Opinions on Biosimilars in Immunology Data Insights The gold standard of business intelligence. Find out more Sign up for our daily news round-up!

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Hospitals Packaging

HS market forecast to reach $7.8bn across 7MM by 2034

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Market growth will be led by the US, which accounted for over 70% of HS sales in 2024 due to a larger diagnosed population, broader biologic access, and premium pricing.

Packaging

Packaging Communication Hospitals Drug Pricing

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. Reports Biosimilars in Immunology Data Insights The gold standard of business intelligence.

Packaging

Packaging Drug Development Chemotherapy Biosimilars

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Pricing

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

Pharmaceutical Technology

JULY 2, 2025

Kaftrio loses patient protection in 2037, at which point biosimilars are set to enter the market. How will RFK Jr’s American dream for vaccines play out? Trikafta, known under the brand name Kaftrio in Europe, is the best-selling cystic fibrosis drug in the world, generating revenue of $11.02bn in 2024.

Packaging

Packaging Communication Hospitals Drug Pricing

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

Biosimilars and generics flood the market upon patent loss, which exerts pricing pressure on the branded product. There has been a push by the Trump administration to increase biosimilar and generic drug use in the US. Biosimilars and generics can be as much as 80% cheaper than branded alternatives.

DoH and Children’s National Hospital link for cell and gene therapy

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Hospitals

Hospitals Insurance Coverage and Processing Packaging Communication

CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formulation

Pharmaceutical Technology

JULY 7, 2025

Across the episodes, host Steve Jacobs is joined by seasoned experts in formulation, sterile manufacturing, clinical supplies, commercial packaging, and sustainability to explore a range of challenges across drug development and commercialization, with a focus on getting the best results through contract services.

Packaging

Packaging Drug Development Drug Pricing Biosimilars

Lupin and Zentiva in licence and supply deal for Certolizumab Pegol

Pharmaceutical Technology

JULY 10, 2025

Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets. The partnership will enhance the availability of the affordable biosimilar on a global scale.

Navamedic signs agreement to acquire dne pharma

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Pharmaceutical Manufacturing

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Pharmaceutical Technology

JULY 4, 2025

Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marketing authorisation in the European Union (EU). Clinical trials have demonstrated that both biosimilars match the reference product’s safety, quality and efficacy standards. How will RFK Jr’s American dream for vaccines play out?

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Hospitals

Hospitals Packaging Communication Pharmaceutical Manufacturing

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Compounding

Compounding Packaging Online Pharmacies Communication

Alembic Pharmaceuticals acquires UTILITY therapeutics

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging

Packaging Adverse Reactions Communication Hospitals

EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma

Pharmaceutical Technology

JULY 11, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Bevacizumab Biosimilar in Endometrial Cancer Reports LOA and PTSR Model - Iparomlimab + Tuvonralimab in Nasopharyngeal C. How will RFK Jr’s American dream for vaccines play out? Data Insights The gold standard of business intelligence. Find out more Sign up for our daily news round-up!

Packaging

Packaging Hospitals Biosimilars Communication

J&J eyes prostate cancer label expansion for Akeega

Pharmaceutical Technology

JULY 7, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Labelling

Labelling Packaging Communication Hospitals

Teva to collaborate with Fosun Pharma for TEV-56278

Pharmaceutical Technology

JUNE 17, 2025

In February 2025, Teva and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to Johnson & Johnson’s Stelara (ustekinumab). Can pharma tariffs “Make America Manufacture Again”? This targeted method could significantly improve patient outcomes across multiple oncology diseases.

Communication

Communication Hospitals Drug Development Packaging

Why can’t the US figure out weight loss drug prices?

Pharmaceutical Technology

JUNE 27, 2025

Novo Nordisk took a different route with Hims & Hers – the drugmaker partnered with the telehealth company to offer Wegovy via a bundled membership package in April 2025. Mochi Health is even the subject of a lawsuit initiated by Eli Lilly. Give your business an edge with our leading industry insights.

Drug Pricing

Drug Pricing Compounding Packaging Communication

Myasthenia gravis market to reach $10.3bn across 7MM by 2034

Pharmaceutical Technology

JUNE 13, 2025

While the overall MG market is expected to experience growth until 2034, continued generic erosion and the entry of biosimilars will be important barriers to growth. Generic erosion and the entry of biosimilars are expected to be particularly significant in the US MG market. Can pharma tariffs “Make America Manufacture Again”?

Alzheimer’s R&D resurgence driven by $16.8bn in acquisitions in 2025YTD

Pharmaceutical Technology

JUNE 25, 2025

Go deeper with GlobalData Reports Biosimilars in Pharmaceuticals: Peptide-based compositions for Alzh. Can pharma tariffs “Make America Manufacture Again”? Over the past few decades, Alzheimer’s research and development (R&D) has seen a low success rate due to failure to demonstrate efficacy in clinical trials.

Packaging

The Obesity Drug Development Summit has landed in Europe!

pharmaphorum

JUNE 27, 2025

Head to our online registration page to take advantage of our most competitive rates and group packages: [link] Image 27 June, 2025 Bookmark this Oncology Merck at ASCO 2025: Cancer is a constellation of many rare d. R&D If you thought GLP-1 agonists were transformative - wait until you see what’s next.

Drug Development

Drug Development Diabetes Pharmaceutical Companies Pharmaceutical Companies

Pharmacist Digest

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Trending Sources

UK enacts law to decentralise manufacture of personalised treatments

HS market forecast to reach $7.8bn across 7MM by 2034

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

FDA approves KalVista’s Ekterly for hereditary angioedema

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

Big pharma braces for revenue headwinds as patent expiries loom

DoH and Children’s National Hospital link for cell and gene therapy

CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formulation

Lupin and Zentiva in licence and supply deal for Certolizumab Pegol

Navamedic signs agreement to acquire dne pharma

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Alembic Pharmaceuticals acquires UTILITY therapeutics

EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma

J&J eyes prostate cancer label expansion for Akeega

Teva to collaborate with Fosun Pharma for TEV-56278

Why can’t the US figure out weight loss drug prices?

Myasthenia gravis market to reach $10.3bn across 7MM by 2034

Alzheimer’s R&D resurgence driven by $16.8bn in acquisitions in 2025YTD

The Obesity Drug Development Summit has landed in Europe!

Stay Connected